{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P49763",
      "entity_text" : "PlGF",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellType" : [ "cl:CL:0000499" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "This concept is consistent with clinical evidences that VEGF-A inhibition, in bevacizumab treated patients, is associated with VEGFR-2 and PlGF increased levels.",
  "reading_complete" : "2020-08-08T12:39:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:34:09Z",
  "trigger" : "levels",
  "evidence" : [ "PlGF increased levels" ],
  "pmc_id" : "4130202",
  "score" : 0
}